Skip to content
Home/Companies/Biotech/Alector
Alector

Alector

Biotech·United States·Exited 2019·Held 3yr
Entry
2016
Hold
3yr
Exit
2019

Who owns Alector?

Alector was owned by SV Health Managers through Dementia Discovery Fund (2015 vintage) from 2016 to 2019, exited via IPO.

Hand-verified · updated 2026-07-16

SV Health Managers
Investor
SV Health Managers
Dementia Discovery Fund · 2015 · Impact

Key facts

HQUnited States
SectorBiotech
StatusAcquired
Websiteinvestors.alector.com
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2019

More from Dementia Discovery Fund

Other portfolio companies in the same fund.

Montara Therapeutics
Active
BiotechUnited States· 2024
TRIMTECH Therapeutics
TRIMTECH Therapeutics
Active
BiotechUK· 2023
Amphista Therapeutics
Amphista Therapeutics
Active
BiotechUK· 2022
AviadoBio
AviadoBio
Active
BiotechUK· 2021
Harness Therapeutics
Harness Therapeutics
Active
BiotechUK· 2020
NRG Therapeutics
Active
BiotechUK· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Alector

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Alector.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue